Summit Therapeutics Inc. Quarterly Operating Margin in % from Q4 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Summit Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2023.
  • Summit Therapeutics Inc. Operating Margin for the quarter ending June 30, 2023 was -268K %, a 6725% decline year-over-year.
  • Summit Therapeutics Inc. annual Operating Margin for 2022 was -10.2K %, a 115% decline from 2021.
  • Summit Therapeutics Inc. annual Operating Margin for 2021 was -4.76K %, a 23% increase from 2020.
  • Summit Therapeutics Inc. annual Operating Margin for 2020 was -6.19K %, a 67.3% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -268K -264K -6725% Apr 1, 2023 Jun 30, 2023
Q1 2023 -129K -124K -2535% Jan 1, 2023 Mar 31, 2023
Q4 2022 -10.2K -5.46K -115% Oct 1, 2022 Dec 31, 2022
Q3 2022 -8.14K -4.03K -97.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -3.93K +7.31K +65% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.9K +3.45K +41.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -4.76K +1.42K +23% Oct 1, 2021 Dec 31, 2021
Q3 2021 -4.11K Jul 1, 2021 Sep 30, 2021
Q2 2021 -11.2K Apr 1, 2021 Jun 30, 2021
Q1 2021 -8.35K Jan 1, 2021 Mar 31, 2021
Q4 2020 -6.19K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.